Tevogen Bio Holdings Inc Earnings

The next earnings date for Tevogen Bio Holdings Inc is November 14, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Tevogen Bio Holdings Inc Earnings

Report DateEstimated Earnings Per Share
11/14/2025$-0.06

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Tevogen Bio Holdings Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/14/2025After Market$-0.0340.00%
08/14/2024After Market$-0.04---
05/27/2024After Market$-0.26---

More About Tevogen Bio Holdings Inc

Country
USA
Full Time Employees
18

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920 which is in preclinical trial for treating cervical cancer; TVGN 960 which is in preclinical trial for treating oropharyngeal cancer; TVGN 601 which is in preclinical trial for treating multiple sclerosis; TVGN 930 which is in preclinical trial for treating Epstein-Barr virus associated lymphomas; and TVGN 116 a product candidate targeted at hepatitis B and is in preclinical trial. Tevogen Bio Holdings Inc. was formerly known as Tevogen Bio Inc. and changed its name to Tevogen Bio Holdings Inc. in February 2024. The company was founded in 2020 and is headquartered in Warren, New Jersey.

Tevogen Bio Holdings Inc Earnings” Can Refer to the Tevogen Bio Holdings Inc Earnings Date

Some people say “Tevogen Bio Holdings Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Tevogen Bio Holdings Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Tevogen Bio Holdings Inc Stock on the Earnings Date

If you own Tevogen Bio Holdings Inc stock (TVGN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Tevogen Bio Holdings Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Tevogen Bio Holdings Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Tevogen Bio Holdings Inc Earnings

You can contact us any time if you would like to ask questions about Tevogen Bio Holdings Inc earnings or anything else related to the stock market.